Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

AR gene not major factor in female hair loss; different from male hair loss.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Dermal papilla cells are key for hair growth and could help us understand and treat hair loss.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Oxidative stress increases in early hair loss, and family history plays a role; antioxidants may help future treatments.

Various treatments exist for hair loss, but more research is needed for better options.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Hair India 2012 was a successful international event focused on combating fake trichology practices and discussing various hair health topics.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Male hair loss is mainly due to thinner hair, not less hair.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

Hair transplantation and micrografting are effective for cosmetic facial enhancement, requiring careful technique and postoperative care for successful outcomes.

Hair loss affects self-esteem; patients seek effective, low side-effect treatments.

Hair loss caused by genetics and hormones; more research needed for treatments.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Women find hair loss more distressing than men and often underestimate it, needing more public awareness and professional support.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hair loss needs more research for better treatments.